H2O Innovation (OTCMKTS:HEOFF) and Misonix (NASDAQ:MSON) are both small-cap industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings.
This table compares H2O Innovation and Misonix’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Volatility and Risk
H2O Innovation has a beta of 0.26, meaning that its stock price is 74% less volatile than the S&P 500. Comparatively, Misonix has a beta of 0.29, meaning that its stock price is 71% less volatile than the S&P 500.
This is a breakdown of current ratings for H2O Innovation and Misonix, as provided by MarketBeat.
||Strong Buy Ratings
Misonix has a consensus target price of $26.00, suggesting a potential upside of 41.07%. Given Misonix’s higher probable upside, analysts clearly believe Misonix is more favorable than H2O Innovation.
Insider & Institutional Ownership
12.9% of Misonix shares are owned by institutional investors. 23.8% of Misonix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares H2O Innovation and Misonix’s revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
H2O Innovation has higher revenue and earnings than Misonix.
Misonix beats H2O Innovation on 6 of the 11 factors compared between the two stocks.
H2O Innovation Company Profile
H2O Innovation Inc. provides integrated water treatment solutions based on membrane filtration technology in Canada, the United States, Spain, China, the United Arab Emirates, Mexico, France, Egypt, and internationally. It designs, manufactures, and markets systems and equipment for the production of drinking water and industrial process water, reclamation and reuse of water, and desalination of seawater and treatment of wastewater. The company also provides products, as well as membrane filtration systems' spare parts, such as pumps, valves, membranes, filters, media, and other replacement parts of water or wastewater treatment system; and specialty chemicals for membrane pre-treatment applications, as well as develops blends for maintenance, preservation, and cleaning of membrane systems. In addition, it offers specialty coagulants for conventional and membrane filtration systems, as well as flocculants; a line of couplings and fittings for industrial and municipal applications; cartridge filter housings, bag filters, strainers, and cartridge filter elements; and maple syrup products and equipment, such as evaporators, reverse osmosis separators, monitoring solutions, membranes, fittings, tubing, tanks, press filters, and other products related to the maple syrup industry. Further, the company provides operation and maintenance services for water and wastewater treatment systems; and public works services, which include street maintenance, drainage maintenance, and solid waste collection, as well as leases containerized water or wastewater treatment systems, and pilot units. It primarily serves municipalities and local governments; communities and private developments; energy and power plants; food and beverages industries; oil and gas markets; mining and workers camps; and other industrial segments. The company was founded in 2000 and is headquartered in Quebec City, Canada. H2O Innovation Inc. is a subsidiary of Amsterdams Effectenkantoor B.V.
Misonix Company Profile
Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company’s ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.
Receive News & Ratings for H2O Innovation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H2O Innovation and related companies with MarketBeat.com's FREE daily email newsletter.